Vaginal Bleeding

ByShubhangi Kesavan, MD, Cleveland Clinic Learner College of Medicine, Case Western Reserve University
Reviewed/Revised Jun 2024
View Patient Education

The etiology, diagnosis, and management of abnormal vaginal or uterine bleeding vary by reproductive phase or status: premenarche, reproductive age, pregnancy, or menopause. Abnormal vaginal bleeding in nonpregnant reproductive-aged and postmenopausal women is discussed here.

(See also vaginal bleeding in early pregnancy or late pregnancy and in children.)

Etiology of Vaginal Bleeding

Patients may seek medical attention for vaginal bleeding, but the bleeding can originate anywhere in the female genital tract, including the vulva, vagina, cervix, uterus, fallopian tubes, or ovaries. When vaginal bleeding originates in the uterus, it is called abnormal uterine bleeding (AUB). In addition, bleeding that appears to be vaginal may originate from the urinary or gastrointestinal tract.

Vulvar bleeding causes include

  • Infectious or inflammatory diseases, in particular, diseases that cause ulcers or erosions (eg, genital herpes simplex, syphilitic chancre, bullous pemphigoid) or those that cause vulvar pruritus may result in bleeding from excoriations, if patients scratch the lesions and/or surrounding skin or mucosa (eg,lichen sclerosus).

  • Physical trauma (eg, falling with direct impact to the vulva, sexual assault)

  • Vulvar procedures (eg, biopsy or female genital mutilation)

  • Benign lesions (eg, epidermal cysts, condyloma, angiokeratoma, chondroid)

  • Vulvar intraepithelial neoplasia or squamous cell carcinoma or other malignancies (eg, melanoma)

Any vulvar lesion may bleed from friction (eg, from contact with clothing).

Vaginal bleeding causes include

  • Genitourinary syndrome of menopause

  • Infections or lesions caused by infection (eg, bacterial vaginosis, condyloma, vaginal ulcers)

  • Physical trauma (eg, insertion of objects for sexual or other reasons, retained tampon, sexual assault)

  • Radiation therapy

  • Benign lesions (eg, Gartner duct cyst, vaginal adenosis, polyp, urethral caruncle)

  • Vaginal intraepithelial neoplasia or squamous cell carcinoma or other malignancies (eg, clear cell carcinoma)

  • Rarely, toxic epidermal necrolysis and Stevens-Johnson syndrome

Causes of abnormal uterine bleeding(AUB) are categorized by the PALM-COEIN classification system into structural and nonstructural etiologies (1, 2).

Structural etiologies of AUB include

  • Polyps of the cervix or endometrium

  • Adenomyosis

  • Leiomyoma (uterine fibroids)

  • Malignancy or hyperplasia of the uterus or cervix

Nonstructural etiologies of AUB include

  • Coagulopathy

  • Ovulatory dysfunction

  • Endometrial (eg, chronic endometritis)

  • Iatrogenic (eg, breakthrough bleeding while taking oral contraceptives)

  • Not yet classified

Ovulatory dysfunction is the most common cause of AUB in reproductive-aged women. There are many other specific reasons for AUB within the PALM-COIEN categories (see table Some Causes of Uterine Bleeding in Nonpregnant Adult Women).

The PALM-COIEN system describes mainly etiologies of bleeding from the uterine corpus. Causes of cervical bleeding include

  • Cervicitis

  • Cervical endometriosis

  • Severe pelvic organ prolapse

  • Physical trauma (eg, insertion of objects for sexual or other reasons, sexual assault)

  • Cervical polyps, cysts, papilloma/warts

  • Cervical intraepithelial neoplasia or cancer

Bleeding from the ovaries or fallopian tubes is not a common cause of vaginal bleeding. Bleeding from these organs is more likely to be intraabdominal; however, blood may pass through the uterus and be noticed only when it passes through the vagina. Causes of bleeding from the fallopian tubes include

Ovarian bleeding causes include

PALM-COEIN classification system

Table
Table

Etiology references

  1. 1. American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins—Gynecology: Practice Bulletin No. 128: Diagnosis of abnormal uterine bleeding in reproductive-aged women. Obstet Gynecol. 2012 (reaffirmed 2024);120(1):197-206. doi:10.1097/AOG.0b013e318262e320

  2. 2. American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins—Gynecology: Practice Bulletin No. 136: Management of abnormal uterine bleeding associated with ovulatory dysfunction. Obstet Gynecol2013 (reaffirmed 2022); 122 (1):176-185. doi: 10.1097/01.AOG.0000431815.52679.bb

Pathophysiology of Vaginal Bleeding

Most abnormal vaginal bleeding involves

  • Hormonal abnormalities in the hypothalamic-pituitary-ovarian axis

  • Benign structural disorders (eg, uterine fibroids)

  • Infectious or inflammatory (eg, cervicitis, chronic endometritis) disorders

  • Gynecologic cancers

  • Bleeding disorders (uncommon)

Ovulatory dysfunction is due to endocrine abnormalities. As a result, ovulation does not occur or occurs infrequently or irregularly. During an anovulatory cycle, the corpus luteum does not form, and thus the normal cyclical secretion of progesterone does not occur. Without progesterone, estrogen causes the endometrium to continue to proliferate, eventually outgrowing its blood supply. The endometrium then sloughs and bleeds incompletely, irregularly, and sometimes profusely or for a long time.

Benign structural disorders (eg, uterine fibroids, adenomyosis) may cause abnormal bleeding because they interfere with the function of the myometrium (muscle layer of the uterus). Endometrial or cervical polyps have dense, fragile blood vessels and bleed easily.

Evaluation of Vaginal Bleeding

Abnormal vaginal bleeding may be acute or chronic. When a patient presents with vaginal bleeding, the first 2 priorities are determining whether the bleeding is heavy enough to require emergency care and whether the patient is pregnant. Unrecognized pregnancy must be suspected and diagnosed in women of reproductive age because some causes of vaginal bleeding during pregnancy (eg, ectopic pregnancy) are life threatening.

History

History of present illness should begin with asking the patient about the onset of the bleeding, including the timing and relationship to any causative factors. How the patient noticed the bleeding and how certain she is that the source is the vagina should be discussed. Bleeding on toilet tissue or in the toilet, and sometimes blood on underwear or a pad, may be from the genital, urinary, or gastrointestinal tract.

Questions should be asked to elicit the characteristics of the bleeding:

  • Onset: Start of the bleeding and whether there were any possible causative factors

  • Pattern: Intermittent or constant; relationship to menstrual cycle or sexual activity

  • Duration

  • Volume: Spotting, light bleeding, normal menstrual flow, or heavier; soaking a pad or tampon every 1 to 2 hours, passing blood clots, and/or feeling faint suggest heavy bleeding

  • Relationship to other symptoms: Presence of pelvic or abdominal pain or pressure, fever, or urinary or bowel symptoms

Clinicians should also ask about the following:

  • Menstrual history, including date of last normal menstrual period, age at menopause (when appropriate), cycle length and regularity, quantity and duration of typical menstrual bleeding

  • Previous episodes of abnormal bleeding and whether the cause was identified

  • Sexual history, including possible history of sexual assault

Ranges for normal menses are as follows: frequency (every 24 to 38 days), regularity (length of the longest and shortest cycles vary by < 7 to 9 days), duration (4.5 to 8 days), and volume of blood loss (5 to 80 mL) (see table Normal Menstrual Parameters).

Review of systems should seek symptoms of possible causes, including the following:

Past medical history should identify disorders known to cause vaginal bleeding, including a recent pregnancy, chronic irregular menses, or known structural disorders (eg, uterine fibroids, adenomyosis). Clinicians should identify risk factors for gynecologic cancers, including endometrial cancer (obesity, diabetes, unopposed estrogen [either endogenous, due to chronic ovulatory dysfunction, or exogenous, due to prolonged estrogen use without a progestin]), or family history of colorectal cancer or endometrial cancer before age 50 (suggesting Lynch syndrome), and cervical cancer (abnormal or inadequate cervical cancer screening, immunosuppression).

Medications should include specific questions about use of hormonal contraceptives, menopausal hormone therapy, other hormones, and other medications that can cause AUB (eg, anticoagulants, progestin-only contraceptives).

Family history of bleeding disorders or gynecologic cancers should be discussed.

Social history should include questions about domestic violence or recent history of sexual assault.

Physical examination

Vital signs are reviewed for fever and signs of hypovolemia (eg, tachycardia, hypotension). During the general examination, clinicians should look for signs of anemia (eg, conjunctival pallor).

The abdomen is examined for distention, tenderness, and masses (particularly an enlarged uterus).

A pelvic examination is done. External inspection and speculum examination help identify lesions of the vulva, vagina, cervix, and urethra or evidence of physical trauma. Bimanual examination is done to evaluate uterine size, mobility, consistency, tenderness, and contour (eg, fibroids cause an uneven shape) and ovarian size, mobility, and tenderness. If gastrointestinal bleeding is suspected, rectal examination is done.

Patterns of physical examination findings that suggest a systemic or gynecologic disorder that can cause abnormal uterine bleeding include:

Red flags

The following findings are of particular concern:

  • History of irregular menses, unprotected sex, nausea, or breast tenderness: Bleeding may be pregnancy-related

  • Heavy, persistent bleeding: May result in anemia, hemodynamic instability, or shock

  • Post-coital bleeding: Possible cervical cancer

  • Postmenopausal vaginal bleeding: Possible uterine cancer

Interpretation of findings

Significant hypovolemia or hemorrhagic shock is unlikely except for heavy bleeding after a prolonged duration of amenorrhea or due to uterine fibroids, or, rarely, due to a ruptured ovarian cyst.

In reproductive-aged women, examination may detect a genital tract lesion or pelvic mass or other findings (eg, pelvic tenderness, cervical friability) that identifies the source of bleeding and suggests a cause. Vulvar, vaginal, or cervical lesions or vaginal or cervical discharge may be from an infection or a benign or malignant neoplasm. Cervical bleeding without a grossly visible lesion may be cervical intraepithelial neoplasia or cancer. A firm, nodular, enlarged, mobile uterus is likely to be uterine fibroids. A globular, soft, enlarged uterus is likely to be adenomyosis. However, a fixed pelvic mass suggests cancer or an inflammatory disorder (eg, pelvic inflammatory disease).

For patients with a normal pelvic examination and irregular menses consistent with ovulatory dysfunction, further evaluation should be done to identify an endocrine disorder. In patients with irregular vaginal bleeding who started progestin-only contraceptives within the past 6 months or who have been taking estrogen-progestin contraceptives for ≥ 2 years, the cause may be due to iatrogenic ovulatory dysfunction or endometrial atrophy.

In postmenopausal women with vaginal bleeding, further evaluation should be done for gynecologic cancer.

Testing

All patients of reproductive age with vaginal bleeding require a urine or blood pregnancy testVaginal Bleeding During Early Pregnancy and Vaginal Bleeding During Late Pregnancy).

Blood tests are done to evaluate suspected complications or etiologies, which may include (1)

  • Anemia: For heavy, prolonged, persistent, or recurring bleeding, a complete blood count (CBC); if anemia is identified and is not obviously due to iron deficiency (eg, based on microcytic, hypochromic red blood cell [RBC] indices), iron studies (serum iron, total iron binding capacity [TIBC], and ferritin); for acute, heavy bleeding, a blood type and cross-match in case blood transfusion is needed

  • Endocrine disorders: Depending on history and symptoms, tests for thyroid disease (thyroid-stimulating hormone), polycystic ovary syndrome (total testosterone

  • Hepatic disease: Liver tests

A positive screen of a medical history for risk factors for a bleeding disorder includes any of the following (2):

  • Heavy menses since menarche

  • One of the following: Postpartum hemorrhage, surgery-related bleeding, or bleeding with dental work

  • Two or more of the following: bruises > 5 cm in diameter at least 1 to 2 times a month, epistaxis 1 to 2 times a month, frequent gum bleeding, or family history of bleeding symptoms

Imaging includes transvaginal ultrasound if women have any of the following:

Endometrial sampling is indicated for patients with abnormal uterine bleeding combined with

  • Age > 45 years

  • Age < 45 with unopposed estrogen exposure (as occurs in women with a high body mass index, polycystic ovary syndrome) or failed medical management

  • In postmenopausal bleeding, endometrial thickening > 4 mm on ultrasound or any bleeding in patients at high risk of endometrial cancer

  • Risk factors for uterine cancer

Sampling can be done by endometrial biopsy or dilation and curettage (D & C).

Secondary evaluation with saline-infusion sonohysterography helps to characterize small intrauterine lesions (eg, endometrial polyps, submucous myomas). Hysteroscopy is the gold standard for diagnosis of intrauterine structural causes of abnormal uterine bleeding.

Vulvar or vaginal biopsy is done if a lesion found on examination is potentially malignant or the diagnosis is uncertain.

Cervical biopsy is done if the cervix is the source of the bleeding, and there is a cervical lesion or abnormal Papanicolaou (Pap) test result that indicates biopsy. A Pap test is done for cervical bleeding if there are no abnormal findings on examination, and the patient has not had a recent Pap test.

Evaluation references

  1. 1. American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins—Gynecology: Practice Bulletin No. 128: Diagnosis of abnormal uterine bleeding in reproductive-aged women. Obstet Gynecol. 2012 (reaffirmed 2024);120(1):197-206. doi:10.1097/AOG.0b013e318262e320

  2. 2. Kouides PA, Conard J, Peyvandi F, Lukes A, Kadir R: Hemostasis and menstruation: appropriate investigation for underlying disorders of hemostasis in women with excessive menstrual bleeding. Fertil Steril. 2005;84(5):1345-1351. doi:10.1016/j.fertnstert.2005.05.035

Treatment of Vaginal Bleeding

The 2 main objectives of managing vaginal bleeding are

  • Control active bleeding

  • Treat or manage the underlying cause to prevent future episodes

Vaginal bleeding may be severe, and hemodynamic instability or hemorrhagic shock requires immediate treatment with fluid management and blood transfusion to correct severe anemia. Women who are hemodynamically stable with mild to moderate anemia can often be managed with fluid replacement. Iron deficiency anemia may require several months of supplemental oral iron.

Acute, severe bleeding is most likely to occur from a vaginal laceration, cervical cancer, or abnormal uterine bleeding.

Any vaginal laceration is repaired.

For bleeding from cervical cancer, the patient should be managed in the operating room by an experienced gynecologic surgeon. Cauterizing the lesion may be possible, but more extensive surgery may be required.

Surgical treatment is required in cases of a hemodynamically unstable patient with severe bleeding or if medical treatment is contraindicated or has failed. Surgical treatments include: dilatation and curettage, hysteroscopic procedures (eg, polypectomy, myomectomy, ablation, intrauterine balloon placement), and interventional radiology-guided bilateral uterine artery embolization. If bleeding cannot be controlled with these measures or if the patient desires definitive treatment, hysterectomy is performed.

After acute management or for nonacute bleeding, treatment of vaginal bleeding is directed at the cause.

Geriatrics Essentials: Vaginal Bleeding

Postmenopausal bleeding (bleeding > 12 months after the final menstrual period) is abnormal and requires further evaluation to exclude cancer, unless it clearly results from withdrawal of exogenous hormones.

In women not taking exogenous hormones, the most common cause of postmenopausal bleeding is endometrial atrophy, but endometrial hyperplasia or cancer should be ruled out.

In some older women, physical examination of the vagina can be difficult because lack of estrogen leads to vaginal atrophy with narrowness and tenderness and sometimes labial adhesions. For these patients, a pediatric speculum may be more comfortable.

Key Points

  • Etiology, diagnosis, and management of abnormal vaginal or uterine bleeding vary by reproductive phase or status: premenarche, reproductive age, pregnancy, or menopause.

  • Abnormal uterine bleeding may be due to structural (polyp, adenomyosis, fibroids, malignancy) or nonstructural (coagulopathy, ovulatory dysfunction, endometrial, or iatrogenic) disorders. Ovulatory dysfunction is the most common cause of abnormal uterine bleeding during the reproductive years.

  • Patients may seek medical attention for vaginal bleeding, but the bleeding can originate anywhere in the female genital tract, including the vulva, vagina, cervix, uterus, fallopian tubes, or ovaries, or also from the urinary or gastrointestinal tract.

  • Administer a pregnancy test in women of reproductive age with abnormal vaginal bleeding even when history does not suggest pregnancy.

  • Evaluate postmenopausal vaginal bleeding with endometrial sampling or other tests for cancer.

Drugs Mentioned In This Article
quizzes_lightbulb_red
Test your KnowledgeTake a Quiz!
Download the free Merck Manual App iOS ANDROID
Download the free Merck Manual App iOS ANDROID
Download the free Merck Manual App iOS ANDROID